Done sou Salè H1B

Akèy › Anplwayè › Astellas Pharma Global Development, Inc.

Astellas Pharma Global Development, Inc.: Salè H-1B ak pajon

Astellas Pharma Global Development, Inc. depoze 32 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 32. Medyèn salè yo ofri a: $148,797.

Demann (LCA)32
Certifye32
Adrès anplwayèNorthbrook, IL
Anplwayè H-1B depannNon
Salè medyan ofri$148,797
Mwatye salè yo$131,022–$183,081
10yèm–90yèm pousantaj$125,300–$190,405

Èske Astellas Pharma Global Development, Inc. pajone visa H-1B?

Astellas Pharma Global Development, Inc. depoze 32 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 1, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.

Demands Green Card (PERM) pou Astellas Pharma Global Development, Inc.: 7 →

Salè pa tit travay

Tit travayLCASalè medyan
Senior Centralized Monitoring Manager2$167,475
Statistical Scientist2$139,953
Manager, Biostatistics2$130,988
Chief Medical Officer2$409,551
Senior Manager, Clinical Data Digital Health Lead1$122,470
Information and Systems Strategy Manager1$130,000
Senior Manager, CPED Oncology [20357.321.8]1$131,914
Senior Manager Scientific Content Excellence1$130,187
Sr. Manager Real World Data & Evidence - Analytics1$125,300
Sr. Associate, Regulatory Affairs1$87,000
Senior Manager, Biostatistics - Oncology1$125,300
Senior Manager, CPED Oncology1$161,459
Director, Translational Bioinformatics1$182,300
Principal Data Manager1$159,962
Senior Information & Systems Strategy Manager1$154,994
Associate Director, HEOR Oncology1$188,000
Project Manager1$132,500
Statistical Programming Lead1$131,300
Senior Regulatory Operations Manager1$146,286
HEOR Product Lead1$189,800
Gene Therapy Portfolio Strategy Partner1$190,448
Associate Regulatory Operations Manager1$124,727
Global Modeling and Simulation Scientist1$165,568
Clinical Trial Lead1$190,016
Specialist, Regulatory Affairs (RA) CMC1$151,308
Associate Director - Real World Data Scientist1$140,275
Clinical Operation Lead1$195,000
Data Management Lead1$185,425

Aplikasyon pa ane fiskal

Ane fiskalLCASalè medyan
FY202310$130,094
FY20247$135,346
FY202512$167,759
FY20263$185,425

Nivo salè prevanlan

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Kote travay yo ye

Okipasyon

Dènye aplikasyon yo

Tit travaySalè bazKoteSoumètDat kòmansmanEstati
Data Management Lead$185,425
Nivo IV
Northbrook, ILJun 1, 2026Aug 7, 2026Certifye
Clinical Operation Lead$195,000–$316,550
Nivo IV
Danville, CAMay 8, 2026May 26, 2026Certifye
Associate Director - Real World Data Scientist$140,275–$260,000
Nivo IV
Northbrook, ILMar 16, 2026Jun 8, 2026Certifye
Specialist, Regulatory Affairs (RA) CMC$151,308
Nivo IV
Westborough, MAJul 14, 2025Jul 21, 2025Certifye
Global Modeling and Simulation Scientist$165,568
Nivo II
Pflugerville, TXJun 5, 2025Oct 1, 2025Certifye
Clinical Trial Lead$190,016
Nivo II
Northbrook, ILJun 2, 2025Oct 1, 2025Certifye
Senior Centralized Monitoring Manager$169,950
Nivo IV
Cary, NCApr 1, 2025Apr 15, 2025Certifye
Gene Therapy Portfolio Strategy Partner$190,448
Nivo III
Northbrook, ILMar 21, 2025Aug 15, 2025Certifye
Associate Regulatory Operations Manager$124,727
Nivo IV
Northbrook, ILMar 13, 2025Apr 25, 2025Certifye
Senior Regulatory Operations Manager$146,286–$218,800
Nivo III
Buffalo Grove, ILNov 25, 2024May 13, 2025Certifye
HEOR Product Lead$189,800–$316,300
Nivo III
Jersey City, NJNov 11, 2024Nov 18, 2024Certifye
Statistical Scientist$136,136–$153,000
Nivo IV
Plano, TXOct 22, 2024Mar 15, 2025Certifye
Chief Medical Officer$390,602
Nivo IV
Northbrook, ILOct 18, 2024Oct 18, 2024Certifye
Chief Medical Officer$428,500
Nivo IV
Northbrook, ILSep 24, 2024Oct 1, 2024Certifye
Manager, Biostatistics$135,346–$153,000
Nivo IV
Mishawaka, INSep 23, 2024Oct 1, 2024Certifye
Statistical Programming Lead$131,300–$175,000
Nivo III
Northbrook, ILSep 19, 2024Jan 31, 2025Certifye
Project Manager$132,500
Nivo II
Northbrook, ILJun 3, 2024Jun 17, 2024Certifye
Statistical Scientist$143,770–$183,800
Nivo II
Santa Clara, CAMay 8, 2024Oct 1, 2024Certifye
Manager, Biostatistics$126,630–$183,800
Nivo IV
Northbrook, ILApr 24, 2024Oct 1, 2024Certifye
Senior Information & Systems Strategy Manager$154,994
Nivo IV
Northbrook, ILFeb 15, 2024Jul 12, 2024Certifye
Associate Director, HEOR Oncology$188,000
Nivo II
Morris Plains, NJJan 4, 2024Mar 4, 2024Certifye
Director, Translational Bioinformatics$182,300–$243,000
Nivo IV
Belmont, MASep 12, 2023Oct 25, 2023Certifye
Principal Data Manager$159,962
Nivo IV
Northbrook, ILAug 1, 2023Aug 7, 2023Certifye
Senior Manager Scientific Content Excellence$130,187–$167,000
Nivo III
Elgin, ILJun 20, 2023Aug 7, 2023Certifye
Sr. Manager Real World Data & Evidence - Analytics$125,300–$167,000
Nivo II
Northbrook, ILJun 8, 2023Jun 8, 2023Certifye
Sr. Associate, Regulatory Affairs$87,000–$145,000
Nivo II
Northbrook, ILJun 1, 2023Oct 1, 2023Certifye
Senior Manager, Biostatistics - Oncology$125,300–$167,000
Nivo II
Northbrook, ILMay 31, 2023Sep 21, 2023Certifye
Senior Manager, CPED Oncology$161,459
Nivo I
Sunnyvale, CAMay 10, 2023Jun 8, 2023Certifye, apre retire
Senior Centralized Monitoring Manager$165,000
Nivo IV
Northbrook, ILApr 17, 2023Jun 5, 2023Certifye
Senior Manager, Clinical Data Digital Health Lead$122,470–$198,800
Nivo IV
Northbrook, ILNov 30, 2022Dec 12, 2022Certifye
Information and Systems Strategy Manager$130,000
Nivo IV
Gurnee, ILNov 10, 2022Dec 12, 2022Certifye
Senior Manager, CPED Oncology [20357.321.8]$131,914–$198,800
Nivo I
San Francisco, CAOct 6, 2022Oct 7, 2022Certifye

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).